Name | Classification | Compound | Pharmacological activity | Effect and mechanism | Refs. |
---|---|---|---|---|---|
Wu-Ling-Zhi | Terpenoids | Tormentic acid | Antiangiogenic activity | Controlling abnormal proliferation and cell death resistance of vascular smooth muscle cell without affecting the normal vasculature | [68] |
Euscaphic acid | Anti-inflammatory activity | Inhibition of LPS-induced inflammatory responses by interference with the clustering of TRAF6 with IRAK1 and TAK1 | [69] | ||
Jacoumaric acid | Cytotoxic activity | Significant cytotoxicity effect against P-388 lymphocytic leukemia cell | [10] | ||
3-O-cis-p-coumaroy ltormentic acid | |||||
2α-hydroxy ursolic acid | Anticancer activity | Inhibition of cell proliferation and induction of apoptosis by regulating the p38/MAPK signal transduction pathway | [70] | ||
Pomolic acid | Anti-inflammatory and apoptotic activities | Inhibiting inflammatory response by regulating human neutrophil function | [71] | ||
Ursolic acid | Anticancer and anti-inflammatory activities | Inhibition of tumor growth and induction of apoptosis by modulating the MAPK/ERK and PI3 K/AKT/mTOR pathways; Inhibiting inflammation by suppression of NF-κB, AP-1 and NF-AT activity | [72] | ||
Maslinic acid | Anticancer activity | It can significantly suppress pancreatic tumor growth, induce tumor apoptosis and inhibit NF-κB-regulated anti-apoptotic gene expression | [73] | ||
Wulingzhic acid | Anticoagulative activity | Prolongation of thrombin time and inhibiting platelet aggregation | |||
Wulingzhic acid A | |||||
Wulingzhic acid B | |||||
Trogopteroids A–G | Cytotoxic activity | Cytotoxicity effect against seven human tumor cells, such as HepG2, HL-60 and U937 | [12] | ||
8β-hydroxy-3-oxopimara-15-ene | |||||
Akhdardiol | |||||
Isopimara-7(8),15-dien-3β-ol | |||||
Isopimara-8,15-dien-3β-ol | |||||
Sempervirol | |||||
Macrophynin E | |||||
Ferruginol | Gastroprotective activity | Increasing PGs content, protecting cells from lipid peroxidation and improving gastric ulcer healing | [74] | ||
Epifriedelanol | Antioxidant and anti-inflammatory activities | Attenuating the secondary injury in TBI rats by reducing serum cytokine levels and oxidative stress | [75] | ||
Flavonoids | Hinokiflavone | Anti-inflammatory activity | Inhibiting the LPS-induced expression of iNOS and COX-2 and the activation of NF-κB and ERK-1/2 | [76] | |
Amentoflavone | Anti-diabetic activity | Regulating glucose and lipid metabolism via anti-oxidant effects and activating the PI3K/Akt pathway | [77] | ||
Kaempferol-3-O-α-l-(2″E,4″E-di-p-coumaroyl)-rhamnoside | Anticoagulative activity | Significant prolongation of thrombin time | [14] | ||
Kaempferol-3-O-α-l-(3″E,4″E-di-p-coumaroyl)-rhamnoside | |||||
Kaempferol-3-O-α-l-(4″E-p-coumaroyl)-rhamnoside | |||||
Afzelin | Antioxidant and anti-inflammatory activities | Inhibiting particulate matter-induced proinflammatory cytokine mRNA expression and protein secretion; Inhibiting intracellular ROS generation, and p38 mitogen-activated protein kinase and transcription factor activator protein-1 component c-Fos and c-Jun activation | [78] | ||
Quercitrin | Gastroprotective and antioxidant activities | Inhibition of oxidative stress, regulation of mitochondrial dysfunction, and initiation of antioxidant defense | [79] | ||
Lignans | Trogopterins A, B, and C | Cytotoxic activity | Cytotoxicity effect against different types of cancer cells, such as HL-60, HeLa, and MCF-7 | [16] | |
Steroids | Daucosterol | Anti-colitis activity | Inhibiting dextran sulfate sodium (DSS)-induced colitis in mice by relieving inflammation and restoring the number of Treg cells | [80] | |
β-sitosterol | Anti-inflammatory activity | Inhibition of intracellular adhesion molecule 1 expression in TNF-α-stimulated HAEC as well as the binding of U937 cells to TNF-α-stimulated HAEC and attenuating the phosphorylation of nuclear factor-kB p65 | [81] | ||
Cholic acid | Anti-inflammatory activity | Significantly decreasing the content of PGE2 in inflammatory tissue | [82] | ||
Deoxycholic acid | Anti-inflammatory activity | Inhibiting fMLP-induced monocyte and neutrophil chemotaxis and calcium mobilization | [83] | ||
Ursodeoxycholic acid | Anti-inflammatory activity | Ameliorating experimental colonic inflammation in rats at a high dose (50 mg/kg day) by enhancing mucosal defense | [84] | ||
Taurocholic acid | Anti-inflammatory activity | Inhibiting the production of inflammatory mediators, such as NO, PGE2 and histamine | [85] | ||
Others | Bis(7-hydroxyheptyl)decanedioate | Anticoagulative activity | Significant prolongation of thrombin time | [17] | |
Bis(7-hydroxyheptyl)octanedioate | |||||
Protocatechuic acid | Anti-inflammatory and analgesic activities | Significantly decreasing LPO, NO levels and increasing SOD, catalase and GSH levels; significantly increasing the hot pain threshold of experimental mice, and obviously decreasing the frequency of writhing body response | [91] | ||
Hei-Bing-Pian | Steroids | Cholic acid | Anti-inflammatory activity | Significantly decreasing the content of PGE2 in inflammatory tissue | [82] |
Taurocholic acid | Anti-inflammatory activity | Inhibiting the production of inflammatory mediators, such as NO, PGE2, and histamine | [85] |